Kolltan Pharmaceuticals, a privately held biopharmaceutical company,
today announced an agreement with MedImmune, the global biologics
research and development arm of AstraZeneca, under which Kolltan will
in-license a monoclonal antibody targeting the Her3 receptor tyrosine
kinase from MedImmune. Buy Ventolin (Albuterol (Salbutamol)) pills online without prescription Based on the current program status, Kolltan
anticipates initiating Phase 1 clinical testing of this product in the
first quarter of 2014.
As part of the agreement, both companies will have the potential for future cost-, risk- and profit-sharing for this product candidate after Kolltan completes early clinical testing. Buy Prevacid (Lansoprazole) without prescription Financial details of the agreement were not disclosed.
“Kolltan’s team has a substantial track record in oncology and possesses a unique understanding of the science of the HER3 target. Buy Vitamins online As such, we believe Kolltan will optimize development of this innovative and differentiated product candidate, which was first discovered and developed at MedImmune,” said Dr. Bahija Jallal, Executive Vice President, MedImmune.
About Kolltan Pharmaceuticals
Kolltan, a privately held company, is advancing a new generation of therapeutics in oncology and other diseases by creating novel biologic agents that can modulate the function of receptor tyrosine kinases (RTKs). Cancer Genetics Announces Pricing Initial Public Offering Kolltan has a unique understanding of RTKs, their ligands, and cellular signaling and has assembled a team with significant expertise and unique insight into these drug targets. Kolltan’s senior management has a track record of success in bringing products to patients and significant value to shareholders. All Best Rx : Buy drugs online Located adjacent to the Yale Medical School in New Haven, Connecticut, Kolltan is advancing a new generation of therapeutics in oncology and other diseases, in collaboration with the laboratory of Kolltan founder, Dr. Joseph Schlessinger. Drugs Rx Guide : Buy drugs online The Company’s breakthrough R&D pipeline is advancing rapidly, with the first clinical trial program anticipated to begin in the first half of 2014. FDA Approved Rx : Online Pharmacy
“This in-licensing opportunity exemplifies our leadership in and focus on receptor tyrosine kinases and their key role in oncology and other serious diseases”“This in-licensing opportunity exemplifies our leadership in and focus on receptor tyrosine kinases and their key role in oncology and other serious diseases,” commented Dr. Jerry McMahon, Kolltan’s President and Chief Executive Officer. “Kolltan will apply its extensive scientific expertise and R&D drug development experience to prepare for entry into the clinic, including a focus on patient selection strategies. Buy Vasotec (Enalapril) tabs online without prescription Kolltan is excited to advance this innovative product candidate into clinical testing for the broad potential treatment of cancer patients where this target plays a role.”
As part of the agreement, both companies will have the potential for future cost-, risk- and profit-sharing for this product candidate after Kolltan completes early clinical testing. Buy Prevacid (Lansoprazole) without prescription Financial details of the agreement were not disclosed.
“Kolltan’s team has a substantial track record in oncology and possesses a unique understanding of the science of the HER3 target. Buy Vitamins online As such, we believe Kolltan will optimize development of this innovative and differentiated product candidate, which was first discovered and developed at MedImmune,” said Dr. Bahija Jallal, Executive Vice President, MedImmune.
About Kolltan Pharmaceuticals
Kolltan, a privately held company, is advancing a new generation of therapeutics in oncology and other diseases by creating novel biologic agents that can modulate the function of receptor tyrosine kinases (RTKs). Cancer Genetics Announces Pricing Initial Public Offering Kolltan has a unique understanding of RTKs, their ligands, and cellular signaling and has assembled a team with significant expertise and unique insight into these drug targets. Kolltan’s senior management has a track record of success in bringing products to patients and significant value to shareholders. All Best Rx : Buy drugs online Located adjacent to the Yale Medical School in New Haven, Connecticut, Kolltan is advancing a new generation of therapeutics in oncology and other diseases, in collaboration with the laboratory of Kolltan founder, Dr. Joseph Schlessinger. Drugs Rx Guide : Buy drugs online The Company’s breakthrough R&D pipeline is advancing rapidly, with the first clinical trial program anticipated to begin in the first half of 2014. FDA Approved Rx : Online Pharmacy
